Tetra Bio-Pharma Announces New Private Placement Deal

Tetra Bio-Pharma (TSXV:TBP; OTCQB:TBPMF) announced a non-brokered private placement of up to 4,500,000 units at a price of $1.00 per unit for aggregate gross proceeds of up to $4.5 million.

As quoted in the press release:

Each unit will consist of one common share (a “Common Share“) in the Company and one warrant (a “Warrant” and collectively the “Warrants“). Each Warrant will entitle the holder thereof to acquire one Common Share at a price of $1.30, for a period of 36 months from the closing date.

The private placement is expected to close on or about March 31, 2018.

The securities issued pursuant to the private placement will be subject to a four-month hold period from the closing date. Completion of the private placement remains subject to the receipt of all necessary regulatory approvals, including the approval of the TSX Venture Exchange.

Click here to read the full press release.

Source: www.marketwired.com